Nyrada
Menu
NYR:
Market Cap*:
Price Delay ~20min
Home
About Us
Company Overview
Board of Directors
Management
Scientific Advisory Board
Corporate Governance
Our Science
Lead Drug Development
Cholesterol-Lowering Program
Brain Injury Program
Technical Glossary
Drug Development Pathway
Investors
Investor Welcome
ASX Announcements
Brain Injury Program
Cholesterol-Lowering Program
Corporate Announcements
Investor Presentations
Financial Reports
Share Price Information
Key Dates
Investors Glossary
Financial Reports
Annual Reports
Analyst Reports
Annual General Meeting
Past Shareholder Meetings
News & Insights
Presentations & Interviews
Media
Newsletters
Publications
Contact Us
Contact Us
Working at Nyrada
Email Alerts
News & Insights
Home
>
News & Insights
>
Presentations & Interviews
Presentations & Interviews
Media
Newsletters
Publications
Presentations & Interviews
Filter by Year:
2022
2021
2020
2019
14-Sep-2021
Nyrada (ASX:NYR) CEO, James Bonnar presents at the ASX Small and Mid-Cap Conference
14-Sep-2021
Nyrada (NYR: ASX) CEO, James Bonnar interview with Andrew Scott (Proactive Investors) at the ASX Small and Mid-Cap Conference, September 2021
1-Jul-2021
Nyrada (ASX:NYR) interview with Finance News Network, June 2021
23-Feb-2021
Nyrada (ASX:NYR) CEO, James Bonnar provides update on lead drug development programs at Finance News Network CEO Showcase, February 2021
3-Feb-2021
Nyrada (ASX:NYR) discusses collaboration with the Walter Reed Army Institute of Research and UNSW Sydney, February 2021
6-Jan-2021
Nyrada (ASX:NYR) discusses progress in cholesterol-lowering drug program, January 2021
1